Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis
Advanced Materials · 2025-12 · 37 (52)
DOI: 10.1002/adma.202405494 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 10.09.2024. Verfasst von Wenyao Zhen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, IL, 60637, USA. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Mitochondria, Radiation-Sensitizing Agents. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, University of Chicago Medicine Comprehensive Cancer Center, Ludwig Institute for Metastasis Research.
Abstract (Originalsprache)
The efficacy of radiotherapy (RT) is limited by inefficient X‐ray absorption and reactive oxygen species generation, upregulation of immunosuppressive factors, and a reducing tumor microenvironment (TME). Here, the design of a mitochondria‐targeted and digitonin (Dig)‐loaded nanoscale metal‐organic framework, Th‐Ir‐DBB/Dig, is reported to overcome these limitations and elicit strong antitumor effects upon low‐dose X‐ray irradiation. Built from Th 6 O 4 (OH) 4 secondary building units (SBUs) and photosensitizing Ir(DBB)(ppy) 2 2+ (Ir‐DBB, DBB = 4,4′‐di(4‐benzoato)−2,2′‐bipyridine; ppy = 2‐phenylpyridine) ligands, Th‐Ir‐DBB exhibits strong RT‐radiodynamic therapy (RDT) effects via potent radiosensitization with high‐Z SBUs for hydroxyl radical generation and efficient excitation of Ir‐DBB ligands for singlet oxygen production. Th‐Ir‐DBB/Dig releases digitonin in acidic TMEs to trigger disulfidptosis of cancer cells and sensitize cancer cells to RT‐RDT through glucose and glutathione depletion. The released digitonin simultaneously downregulates multiple immune checkpoints in cancer cells and T cells through cholesterol depletion. As a result, Th‐Ir‐DBB/dig plus X‐ray irradiation induces strong antitumor immunity to effectively inhibit tumor growth in mouse models of colon and breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
- Department of Radiation and Cellular Oncology and the Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, 60637, USA.
ORCID-Profile: Wenbin Lin
Förderung
- NCI NIH HHS
- University of Chicago Medicine Comprehensive Cancer Center
- Ludwig Institute for Metastasis Research
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zhen, W., Fan, Y., Germanas, T., Tillman, L., Li, J., Blenko, A. L., Weichselbaum, R. R., & Lin, W. (2025). Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis. Advanced Materials, 37(52). https://doi.org/10.1002/adma.202405494
Vancouver
Zhen W, Fan Y, Germanas T, Tillman L, Li J, Blenko AL, et al. Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis. Advanced Materials. 2025;37(52). doi:10.1002/adma.202405494
BibTeX
@article{Zhen2025,
author = {Zhen, Wenyao and Fan, Yingjie and Germanas, Tomas and Tillman, Langston and Li, Jinhong and Blenko, Abigail L and Weichselbaum, Ralph R and Lin, Wenbin},
title = {Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and Disulfidptosis},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {52},
doi = {10.1002/adma.202405494}
}
EUVIMED